WASHINGTON — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration that avoided its threats of steep tariffs.

What You Need To Know

AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration

Announced Friday, the agreement involves AstraZeneca offering most-favored-nation pricing — matching the lowest prices in other developed nations

This follows a similar deal by Pfizer that Trump announced last month

Both agreements build on an executive order signed by Trump in May, urging drugmakers to lower prices or face government limits

President Donald Trump made the announcement in the Oval

See Full Page